Dr. Sarah El Masry is Regulatory Affairs and Pharmacovigilance leader at Novo Nordisk in the Gulf region. She brings over 17 years of experience in regulatory affairs and pricing, complemented by strong expertise in pharmacovigilance and quality assurance.

Dr. El Masry is actively engaged in regulatory advocacy, contributing to discussions aimed at strengthening regulatory frameworks and enhancing collaboration across the Gulf region. Her areas of interest include innovative medicines, biologics, and the optimization of regulatory processes to support timely patient access.

She holds a Bachelor’s degree in Pharmacy, along with postgraduate qualifications in Health Economics and Total Quality Management.